← Open Payments lookup

RACHEL REED: Open Payments

NPI 1568076669 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$266 in 10 payments from 8 companies in 2025. Trend: 2023 $751 · 2024 $680 · 2025 $266

Food & beverage: $266
CompanyPaymentsAmount
Organogenesis Inc.2$82
Novartis Pharmaceuticals Corporation2$44
Travere Therapeutics, Inc.1$28
Otsuka America Pharmaceutical, Inc.1$25
GENZYME CORPORATION1$24
Calliditas Therapeutics US Inc.1$23
Novo Nordisk Inc1$22
GlaxoSmithKline, LLC.1$17

Products named: NUSHIELD, Fabhalta, JYNARQUE, FABRAZYME, TARPEYO, Ozempic, BENLYSTA, PURAPLY WOUND MATRIX.

Industry payments across KS — which companies pay providers there.